Glycine protects against doxorubicin-induced heart toxicity in mice

Doxorubicin (DOXO) is a well-known cancer chemotherapeutic. However, its toxic effect on the heart limits its clinical application. This study aimed to assess the effectiveness of glycine administration to counteract the DOXO-induction of cardiomyopathy in mice. Fifty male albino mice were divided i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shosha, Mayada I., El-Ablack, Fawzia Z., Saad, Entsar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247571/
https://www.ncbi.nlm.nih.gov/pubmed/36967438
http://dx.doi.org/10.1007/s00726-023-03261-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247571/
https://www.ncbi.nlm.nih.gov/pubmed/36967438
http://dx.doi.org/10.1007/s00726-023-03261-w

Ejemplares similares